Effective December 11th, 2019, Spectrum Health Regional Laboratory’s Immunochemistry laboratory will be upgrading the following tests from the Immunoassay Vidas platform to the Multiplex flow immunoassay Bioplex 2200 platform.
All tests will continue to have the same collection instructions, processing instructions, rejection criteria, specimen stability, turn-around-time, and qualitative reference ranges of negative.
As of November 25th 2019 the following tests for Herpes Simplex Virus (HSV) IgM antibody testing will be obsoleted.
Herpes IgM Antibody Screen – LAB3576
Herpes Simplex Virus (HSV) Antibody Screen, IgM, by EIA, Serum – LAB3578
Herpes Simplex Panel – LAB1230539
In December, serum and urine protein electrophoresis testing will be simplified and standardized. The only testing available will be:
Protein electrophoresis, serum, IFE if indicated
Protein electrophoresis, random urine, do IFE if indicated
Protein electrophoresis, 24 hour urine, do IFE if indicated
In addition, on December 5, 2019, a new panel will be added which reflects expert recommendations for first line testing for monoclonal gammopathy, including plasma cell myeloma and most cases of amyloidosis, called “Monoclonal Gammopathy Screen”
Effective Wednesday, November 13, 2019, the new Mycoplasma genitalium (mgen) assay is now available using the Aptima target nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium to aid in the diagnosis of M. genitalium urogenital infections in male and female patients.
Effective November 5th, testing for Beta-2 Glycoprotein 1 antibodies (IgG and IgM, serum) will change from a reference send out test to Mayo Medical Laboratories to an in-house test available at Spectrum Health Laboratories. This testing is useful for evaluation of patients of suspected antiphospholipid antibody syndrome.
In addition, a new Antiphospholipid Antibody Syndrome Panel will be added which allows for appropriate and complete testing for antiphospholipid antibody syndrome. This panel includes:
Lupus Screen
Cardiolipin IgG and IgM Antibodies
Beta-2 Glycoprotein 1 IgG and IgM Antibodies
To better align with our Allergy Specialists and reduce confusion and costs to patients, we have simplified and standardized our Allergy Panel offerings. These new panels will be available to order beginning Thursday, October 24, 2019. Also effective on this date, several of our old panels will be discontinued.
Troponin T, Blood Level [LAB139] has been replaced with High Sensitivity Troponin T [LAB1230561]
Cardiolipin IgM Ab [LAB3651] and Cardiolipin IgG Ab [LAB3652] have been discontinued. Please order Cardiolipin IgM and IgG Abs [LAB3653]
Drug of Abuse, Pain Clinic, Urine [LAB3382] has been discontinued and replace with Urine Drug Screen with Confirmation (32 Targets) [LAB1230497] or Urine Drug Screen with Confirmation (23 Targets) [LAB1230496]
Blood Drug Screen Comprehensive PC (Pain Clinic) [LAB3574] and Urine Drug Screen Comprehensive PC (Pain Clinic) [LAB3575] have been discontinued and replaced with Drug Analysis Comprehensive, Blood [LAB349] and Drug Analysis Comprehensive, Urine [LAB500]
Kidney Stone Analysis [LAB564] has been updated and has a new order code [LAB1230545]. Note this is a send out to Mayo Clinic Laboratories.
Zinc, Red Blood Cell [LAB1230059] is no longer available and does not have a replacement test.
RA Screen [LAB3324] performed at Spectrum Health Big Rapids Laboratory has been discontinued. The Rheumatoid Factor, Quantitative [LAB206] performed at Spectrum Health Regional Laboratory will be utilized moving forward.
Questions may be directed to Laboratory Services using the “Contact Us” link above.